News

uPerform Crowned Best Training Platform by KLAS Research 2026

uPerform Crowned Best Training Platform by KLAS Research 2026

uPerform Achieves Recognition as Best in KLAS 2026

Recognition reflects the growing importance of training as a strategic capability

uPerform, a prominent player in healthcare training solutions, has proudly earned the title of Best in KLAS for Training and Learning Platforms in 2026. This accolade signifies the company's dedication to contributing significantly to the healthcare industry's continuous improvement. By listening carefully to the feedback from healthcare organizations, KLAS Research has identified uPerform as a leading provider in enhancing the skills and productivity of healthcare professionals.

The acknowledgment, highlighted in the comprehensive report assessing various technological solutions in healthcare, underscores the increasing value placed on training as an essential function within healthcare systems today. As healthcare environments become ever more complex, the need for efficient and reliable training platforms becomes critical.

Understanding the Best in KLAS Recognition

KLAS Research is widely recognized for its impartial evaluation of healthcare technologies. The Best in KLAS title is awarded based on actual experiences and feedback from healthcare professionals who utilize various technology solutions. This award celebrates high customer satisfaction and the proven effectiveness of training platforms in facilitating enhanced patient care.

Eric Grosgogeat, CEO of uPerform, expressed gratitude toward the healthcare organizations that shared their insights and experiences with the platform. According to him, this accolade deeply resonates with the trust that clients establish in uPerform and the positive outcomes produced via their ongoing collaboration.

The Shift Towards Strategic Training

The establishment of the Training and Learning Platforms category reflects a significant transformation within the healthcare sector, where organizations are increasingly prioritizing training. Today's healthcare professionals view training as a foundational element that not only supports the adoption of new technologies but also enhances the overall proficiency of the workforce.

Research Director at KLAS, Niel Oscarson, stated that effective, scalable training methods have become crucial for achieving higher efficiency and user satisfaction in healthcare settings. As organizations strive for digital transformation, implementing robust training solutions has become imperative for sustaining long-term adoption and success.

Dr. Stephanie Lahr, CMO of uPerform, emphasized that current challenges faced by healthcare systems—involving technological advancements, turnover, and shifts in workflow—make training a vital aspect of effective care delivery. She pointed out that training significantly influences organizational performance and fosters an environment of trust.

The Client-Centric Approach

Michael Domingues, EVP of Client Success & Services at uPerform, stated that achieving this recognition stems from the strong partnership and collaboration established between uPerform and its clients. Their trust in uPerform's commitment to technology, support, and continual engagement has helped shape a platform that meets the evolving needs of the healthcare sector. As these organizations advance, the ability to deliver relevant, on-the-job learning becomes crucial.

This accolade strengthens uPerform's commitment to viewing training as an indispensable catalyst in the transformation of healthcare. As advancements in technology continue to emerge, uPerform is dedicated to empowering organizations to navigate change effectively, fostering both employee growth and enhancing patient care capabilities.

About uPerform

uPerform is an innovative platform powered by artificial intelligence, designed for on-demand training and support aimed at enhancing the adoption of leading healthcare and business applications worldwide. With a strong presence among top health systems and global corporations, uPerform assists organizations in maximizing the potential of their Enterprise Resource Planning (ERP), Human Capital Management (HCM), and Electronic Health Record (EHR) software. By facilitating rapid onboarding and elevating user proficiency, uPerform significantly improves overall satisfaction. To learn more about uPerform, visit their official site.

About KLAS Research

KLAS Research plays a crucial role in assisting healthcare providers in making well-informed technology purchase decisions by offering transparent and unbiased insights into vendor performance. Through an extensive network that interviews numerous healthcare providers globally, KLAS ensures the data and ratings are accurate and reflect true client experiences, aiding in driving meaningful changes within the market.

Frequently Asked Questions

What is the significance of the Best in KLAS recognition?

The Best in KLAS designation is awarded to healthcare technology solutions based on direct feedback from users, highlighting high customer satisfaction and effectiveness in improving patient care.

How does uPerform support healthcare organizations?

uPerform helps healthcare organizations by providing AI-powered, just-in-time training and support, facilitating efficient onboarding and user proficiency in using healthcare technologies.

What does the introduction of the Training and Learning Platforms category indicate?

This new category indicates a growing recognition of training within healthcare as a core capability necessary for successful technology implementation and engagement.

How does KLAS evaluate vendors?

KLAS evaluates vendors by gathering insights from healthcare providers through extensive interviews, ensuring that the performance data is accurate and reflects real-world experiences.

What role does training play in healthcare technology adoption?

Training is critical for effective technology adoption, helping users become proficient with new systems, which enhances overall efficiency and patient care outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celebree School Champions Screen-Free Imagination Era

Updated Category News Views 3

Nostalgia often carries us back to simpler times, whether it's building blanket forts or putting on living room plays. Today, these memories are stirring up a movement, and Celebree School is at the heart of the whirlwind. They're rolling out a campaign aptly titled "Boredom Is Where Imagination Begins," aimed at reintroducing children to creativity beyond screens and...

Continue Reading
Omnis Energy's Control Clash Hits Court Showdown

Updated Category News Views 1

Sparks Fly Over Pleasants Power Just when you think you’ve seen every trick in the playbook, along comes another tussle worth its weight in megawatts. Omnis Energy, under its formal name Omnis Pleasants, finds itself in a fiery battle with creditors as the Chapter 11 proceedings heat up over the Pleasants Power Station. With six objections filed ahead of a crucial court...

Continue Reading
ADA Audit Reveals Gaps in Event Management at 2026 Session

Updated Category News Views 1

Hold onto your hats, folks, because the American Diabetes Association (ADA) just dropped a bombshell report with findings that'll make your head spin if you're keyed into the healthcare sector. They’ve wrapped this up in a bow of accountability, but let's dig into the crux of it. Behind the Controversy: The New Orleans Incident This all harks back to an incident on June...

Continue Reading
Medtronic's Q1 2027 Surge Signals Promising Future

Updated Category News Views 2

Medtronic's Impressive Q1 2027: A Closer Look It's not every day you see a healthcare titan like Medtronic (NYSE: MDT) flex some serious muscle on the financial front. As the first quarter of fiscal year 2027 wrapped up, Medtronic delivered a knockout with a reported 13.7% increase in revenue, totaling a hefty $9.8 billion. This wasn't just luck—this was strategic...

Continue Reading
Nauticus Robotics' ROV Activity Boosts Q3 Performance

Updated Category News Views 0

Nauticus Robotics Hits New Stride with ROV Deployments Some days, you're paddling like hell to stay afloat in this market. But for Nauticus Robotics, marking progress amidst turbulent waters, their recent announcement feels like catching a favorable current. Both of Nauticus’ Comanche ROV systems have been deployed for commercial projects, enhancing their third quarter...

Continue Reading
Panoplai's Rocket Ride: No. 320 on Inc. 5000

Updated Category News Views 2

Panoplai's Meteoric Rise in the AI Landscape There's nothing quite like seeing a company break through the noise with numbers that can make even the most jaded investor sit up straight. Panoplai, an AI-powered insights platform, has done just that, snagging a spot at No. 320 on the 2026 Inc. 5000 list of America's fastest-growing private companies with an eye-popping...

Continue Reading
Claroty Earns Top Marks in OT Security Evaluation

Updated Category News Views 4

A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...

Continue Reading
CIC Services Unleashes PortfolioVantage for Property Owners

Updated Category News Views 1

Eyeing Profit in Tenant Liability Insurance CIC Services has cooked up something intriguing for property owners: a shot at fatter profits through their PortfolioVantage program. Launching now, this tenant legal liability strategy promises more than just basic tenant coverage—it's a potential financial boon for savvy landlords willing to dive in. The Gist of...

Continue Reading
Steve McCurry's Mastery Captured in 'Adagio' Exhibition

Updated Category News Views 3

The Reverie of Real Imagery It might be time to give New York a spot on your calendar. Adagio, the latest exhibition at Leica Gallery, reveals the enduring magic of Steve McCurry's lens. Running from September 10th to October 18th, 2026, this event does more than showcase photos—it crafts an experience of human connection. A Dance with History This isn’t just a walk...

Continue Reading
MiniMed's Fiery Start to FY27: Growth Sparks Excitement

Updated Category News Views 3

MiniMed's Bold Initial Move for Fiscal Year 2027 Ah, MiniMed's come out swinging to kick off FY27, and it’s about time somebody did something right. With net sales clocking in at $843 million, marking a 17% spike as reported and 16% organic growth, you'd think we’d be talking about a tech startup, not a diabetes tech stalwart. These folks have been around for ages,...

Continue Reading

Top 5 Most Recently Viewed Articles

Amgen's Rocatinlimab Shows Promise but Faces Market Challenges

Updated Category News Views 231

Amgen's Rocatinlimab Trials: An Overview Recently, Amgen Inc (NASDAQ: AMGN) provided an investor update that highlighted promising results from Phase 3 trials of rocatinlimab, a treatment for atopic dermatitis, more commonly known as eczema. This trial included 726 participants and focused on the drug's ability to alleviate the severity and extent of the condition....

Continue Reading
Discover TerraMaster's D4-320U: Compact Storage Solution

Updated Category News Views 206

Introducing the TerraMaster D4-320U: A New Era in Storage TerraMaster, renowned for its innovative storage solutions, proudly unveils the D4-320U, a compact 1U 4-bay direct-attached storage (DAS) enclosure. Designed specifically for small offices, home users, and IT environments, this cutting-edge device combines a space-saving rackmount design with an impressive 88TB...

Continue Reading
Cohen & Steers Expands Portfolio with Bridgepointe Acquisition

Updated Category News Views 176

Cohen & Steers Income Opportunities REIT's Strategic Expansion Cohen & Steers Income Opportunities REIT, Inc. (CNSREIT) has recently made a significant addition to its real estate portfolio. The company announced the acquisition of Bridgepointe Shopping Center, a well-positioned open-air community shopping center. This strategic move was achieved through a programmatic...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Important Settlement for Evenflo Booster Seat Consumers

Updated Category News Views 307

Key Insights on the Evenflo Booster Seat Settlement Consumers who purchased Evenflo "Big Kid" booster seats may find some relief through a recent class action settlement. The settlement, valued at $3.5 million, addresses allegations that Evenflo Co., Inc. misrepresented the safety and testing of these booster seats. Designed for children over 30 pounds, these seats were...

Continue Reading